INFORMATION

Date: 27-29 November 2008

Fax: +36-1-4586842
Email: symposium@kardio.sote.hu
Visit the homepage of the Heart Center.
CONFERENCE NEWS
Symposium lectures on-line
20 February, 2009
Most of the lectures of the Symposium were published on-line. You can find the video presentations at the top of each lecture abstract. We hope to complete the whole on-line program in the near feature.
Pictures of Semmelweis Symposium 2008
1 January, 2009
You can find the pictures of all the three days of Semmelweis Symposium 2008 here.
Lecture of Prof. Sándor Kovács
31 December, 2008
You can find the whole video-presentation of Prof. Sándor Kovács at "Lectures" on the following page.
Summary
30 November, 2008
More than 500 participants from 20 countries attended Semmelweis Symposium 2008. You can find a detailed summary of the event here. A summary of press echo in the Hungarian media you can find here.
Poster abstracts
27 November, 2008
You can find the poster abstracts of Semmelweis Symposium 2008 here.
Scientific Program - printable version
23 November, 2008
You can download the printable version of the Scientific Program here.
Cardiovascular pharmacogenomics course
22 November, 2008
According to the program of Semmelweis Symposium, Peter Pokreisz (Katholieke Universiteit Leuven, Belgium) will give a lecture (in Hungarian) on cGMP regulatory mechanisms in cardiology at 18:00 Wednesday, 26 November.
Abstract submission period extended
14 November 2008
The deadline for abstract submission was extended until 18 November 2008. More detailes on the Abstract submission form.
On-line registration
4 November. 2008
Participation in the program of Semmelweis Symposium 2008 is free.
However, completion the on-line registration form is required to attend the Symposium.
Abstract submission for poster presentation
3 November, 2008
Abstracts for poster presentation are welcome to the Semmelweis Symposium. Deadline for abstract submission  is 15 November. More detailes on the Abstract Submission Form.
PhD course registration
2 November, 2008
Semmelweis Symposium 2008 was accredited by the School of Doctoral Studies of Semmelweis University. Students attending all the three days of the Symposium will get 2 PhD credits.
OFTEX registration
2 November, 2008
Semmelweis Symposium 2008 was registred to the OFTEX system. Colleagues attending all the three days of the Symposium will get 20 OFTEX credits. For detailed information look for SE-TK/2008-07/00383 at www.oftex.hu .
Final program
30 October, 2008
The final program of the Symposium has been completed. For detailes visit to the Scientific Program pages.
Current trends in Cardiology
18 August. 2008
This year cardiology is in the focus of Semmelweis Symposium. The members of the Heart Center take the opportunity to kindly invite you to this event.
Scientific Program | Pictures | Lectures | Posters | Location

ICD in Heart Failure: Think Outside the Box


Click the picture to watch the presentation!
(You need Adobe Flash Player to watch the presentation...)

Dr. László Littmann received his MD degree from the Semmelweis University Medical School with the Honor of “Sub Auspiciis Rei Publicae Popularis” in 1970, and his PhD degree from the Hungarian Academy of Sciences in 1983. In collaboration with Dr. József Tenczer at the 3rd Department of Medicine, Semmelweis University Medical School, Dr. Littmann was one of the cofounders of clinical cardiac electrophysiology in Hungary. He has been living in the United States since 1987. Dr. Littmann is currently Chief of Cardiology at the Department of Internal Medicine, Carolinas Medical Center in Charlotte, North Carolina, Medical Director of its Heart Failure Program, and since 2000, Professor of Medicine at the University of North Carolina at Chapel Hill. His main clinicaland research interests include electrocardiology, clinical cardiac electrophysiology, arrhythmias, and heart failure. Dr. Littmann received numerous research and teaching awards. He is ad hoc reviewer of all major cardiology journals.

Abstract

Even with optimal medical management, patients with ischemic or nonischemic dilated cardiomyopathy are at risk of sudden cardiac death. Several studies have shown that implantation of a prophylactic cardioverter-defibrillator (ICD) reduces mortality in patients with a left ventricular ejection fraction (EF) of ≤ 35%. The degree of benefit, however, varies among different patient groups. There is minimal or no benefit in persons with advanced renal failure, advanced heart failure, in patients with atrial fibrillation, in those with an EF> 30%, and in the very elderly. Those individuals appear to be the best candidates for prophylactic ICD who, despite optimal medical therapy, continue to have a low EF but good functional performance status without significant renal failure or other comorbidconditions. Patients with ischemic cardiomyopathy and complex ventricular arrhythmias are also more likely to benefit. Obviously there is no benefit from the ICD unless it fires ona life-threatening ventricular arrhythmia but paradoxically those patients who do receive potentially life-saving ICD discharges frequently have a markedly reduced post-shock survival.Understanding these odds, with the help of their physicians, patients need to make personal choices about the desirability of an ICD.
Kardiológiai Központ © 2008 Minden jog fenntartva